Cargando…

DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk

Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes, i.e. gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernard-Gallon, Dominique, Bosviel, Rémy, Delort, Laetitia, Fontana, Luc, Chamoux, Alain, Rabiau, Nadège, Kwiatkowski, Fabrice, Chalabi, Nasséra, Satih, Samir, Bignon, Yves-Jean
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394522/
https://www.ncbi.nlm.nih.gov/pubmed/18454848
http://dx.doi.org/10.1186/1476-4598-7-36
_version_ 1782155432393965568
author Bernard-Gallon, Dominique
Bosviel, Rémy
Delort, Laetitia
Fontana, Luc
Chamoux, Alain
Rabiau, Nadège
Kwiatkowski, Fabrice
Chalabi, Nasséra
Satih, Samir
Bignon, Yves-Jean
author_facet Bernard-Gallon, Dominique
Bosviel, Rémy
Delort, Laetitia
Fontana, Luc
Chamoux, Alain
Rabiau, Nadège
Kwiatkowski, Fabrice
Chalabi, Nasséra
Satih, Samir
Bignon, Yves-Jean
author_sort Bernard-Gallon, Dominique
collection PubMed
description Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damages have been shown to have significantly reduced. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study, 2 functional polymorphisms in a DNA repair gene ERCC2 were analyzed. The population included 911 breast cancer cases, 51 ovarian cancer cases and 1000 controls. The genotyping of 2 SNP (Single Nucleotide Polymorphism) was carried out on the population with the MGB (Minor Groove Binder) probe technique which consists of the use of the allelic discrimination with the Taqman(® )method. This study enabled us to show an increase in risk of breast cancer with no oral contraceptive users and with women exhibiting a waist-to-hip ratio (WHR) > 0.85 for Asn homozygous for ERCC2 312.
format Text
id pubmed-2394522
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23945222008-05-23 DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk Bernard-Gallon, Dominique Bosviel, Rémy Delort, Laetitia Fontana, Luc Chamoux, Alain Rabiau, Nadège Kwiatkowski, Fabrice Chalabi, Nasséra Satih, Samir Bignon, Yves-Jean Mol Cancer Research Breast and ovarian cancers increased in the last decades. Except rare cases with a genetic predisposition and high penetrance, these pathologies are viewed as a polygenic disease. In this concept, association studies look for genetic variations such as polymorphisms in low penetrance genes, i.e. genes in interaction with environmental factors. DNA repair systems that protect the genome from deleterious endogenous and exogenous damages have been shown to have significantly reduced. In particular, enzymes of the nucleotide excision repair pathway are suspected to be implicated in cancer. In this study, 2 functional polymorphisms in a DNA repair gene ERCC2 were analyzed. The population included 911 breast cancer cases, 51 ovarian cancer cases and 1000 controls. The genotyping of 2 SNP (Single Nucleotide Polymorphism) was carried out on the population with the MGB (Minor Groove Binder) probe technique which consists of the use of the allelic discrimination with the Taqman(® )method. This study enabled us to show an increase in risk of breast cancer with no oral contraceptive users and with women exhibiting a waist-to-hip ratio (WHR) > 0.85 for Asn homozygous for ERCC2 312. BioMed Central 2008-05-02 /pmc/articles/PMC2394522/ /pubmed/18454848 http://dx.doi.org/10.1186/1476-4598-7-36 Text en Copyright © 2008 Bernard-Gallon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bernard-Gallon, Dominique
Bosviel, Rémy
Delort, Laetitia
Fontana, Luc
Chamoux, Alain
Rabiau, Nadège
Kwiatkowski, Fabrice
Chalabi, Nasséra
Satih, Samir
Bignon, Yves-Jean
DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title_full DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title_fullStr DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title_full_unstemmed DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title_short DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk
title_sort dna repair gene ercc2 polymorphisms and associations with breast and ovarian cancer risk
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394522/
https://www.ncbi.nlm.nih.gov/pubmed/18454848
http://dx.doi.org/10.1186/1476-4598-7-36
work_keys_str_mv AT bernardgallondominique dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT bosvielremy dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT delortlaetitia dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT fontanaluc dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT chamouxalain dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT rabiaunadege dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT kwiatkowskifabrice dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT chalabinassera dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT satihsamir dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk
AT bignonyvesjean dnarepairgeneercc2polymorphismsandassociationswithbreastandovariancancerrisk